Reverse phase protein arrays enable glioblastoma molecular subtyping-Reference-Cited by-同舟云学术

Reverse phase protein arrays enable glioblastoma molecular subtyping

Published:2016-11-17 Issue:3 Volume:131 Page:437-448
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Hutter Gregor^ORCID,Sailer Martin,Azad Tej Deepak,von Bueren André O.,Nollau Peter,Frank Stephan,Tostado Cristobal,Sarvepalli Durga,Ghosh Arkasubhra,Ritz Marie-Françoise,Boulay Jean-Louis,Mariani Luigi

Funder

Universität Basel

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Neurology,Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-016-2316-5.pdf

Reference32 articles.

1. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997–1003. doi: 10.1056/NEJMoa043331

2. Ene CI, Fine HA (2011) Many tumors in one: a daunting therapeutic prospect. Cancer Cell 20:695–697. doi: 10.1016/j.ccr.2011.11.018

3. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O’Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM, Hayes DN, Network CGAR (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98–110. doi: 10.1016/j.ccr.2009.12.020

4. Brennan C, Momota H, Hambardzumyan D, Ozawa T, Tandon A, Pedraza A, Holland E (2009) Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS One 4:e7752. doi: 10.1371/journal.pone.0007752

5. Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL, Louis DN, Rozenblatt-Rosen O, Suva ML, Regev A, Bernstein BE (2014) Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344:1396–1401. doi: 10.1126/science.1254257

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomics‑based prognostic signature predicts prognosis and immunity in glioma;2022-10-24

2. ERK-dependent suicide gene therapy for selective targeting of RTK/RAS-driven cancers;Molecular Therapy;2021-04

3. Integrative analysis of multi-platform reverse-phase protein array data for the pharmacodynamic assessment of response to targeted therapies;Scientific Reports;2020-12

4. Glioma tumor proteomics: clinically useful protein biomarkers and future perspectives;Expert Review of Proteomics;2020-02-19

5. Integrative analysis of multi-platform reverse-phase protein array data for the pharmacodynamic assessment of response to targeted therapies;2019-09-16